Fu­ji­film ex­pands in US af­ter $100M deal for Atara's man­u­fac­tur­ing site and em­ploy­ees

Atara Bio­ther­a­peu­tics has worked on ad­vanc­ing its al­lo­gene­ic T-cell ther­a­py plat­form for pa­tients with can­cer and au­toim­mune dis­ease for years, with much of the fo­cus on the ever-tricky task of man­u­fac­tur­ing such a ther­a­py. On Wednes­day, the com­pa­ny an­nounced a deal to hand its Cal­i­for­nia man­u­fac­tur­ing site over to Fu­ji­film Diosynth in ex­change for $100 mil­lion up­front and a long-term li­cens­ing deal.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.